In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
6 days 17 hours ago
2 weeks 3 hours ago
2 weeks 7 hours ago
23 weeks 19 hours ago
27 weeks 1 day ago
28 weeks 5 days ago
28 weeks 6 days ago
41 weeks 1 day ago
46 weeks 6 days ago
1 year 5 weeks ago